This study is currently not recruiting participants.

The Efficacy and Safety of Bimatoprost Sustained Release

The Efficacy and Safety of Bimatoprost Sustained Release
Not Recruiting
18 years - 99 years
All
Phase 3
1 Location

Brief description of study

The purpose of this study is to investigate the safety and effectiveness of two different dose strengths in lowering eye pressure in subjects with glaucoma or high eye-pressure.The Bimatoprost sustained release (SR) is a small implant placed inside the eye. It dissolves naturally in the body and contains the bimatoprost drug. The drug is slowly released for about 3 to 4 months.

Detailed description of study

All subjects who take part in this study will get Timolol 0.5% eye drops to use in the eye(s) that do not receive Bimatoprost SR.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Glaucoma, Hypertension, hypertension, Open-Angle Glaucoma, ocular
  • Age: 18 years - 99 years
  • Gender: All
Updated on 19 Feb 2024. Study ID: 821753

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.